DZ2227A1 - Dérivés d'indole nouveaux, procédé pour leur préparation et formulations pharmaceutiques les contenant. - Google Patents

Dérivés d'indole nouveaux, procédé pour leur préparation et formulations pharmaceutiques les contenant.

Info

Publication number: DZ2227A1
Authority: DZ; Algeria
Prior art keywords: preparation; pharmaceutical formulations; formulations containing; indole derivatives; new indole
Prior art date: 1996-05-09

Application number

DZ970074A

Other languages

English (en)

Inventor

David James Rawson

Kevin Nep Dack

Roger Peter Dickinson

James Kim

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-05-09

Filing date

1997-05-07

Publication date

2002-12-25

1997-05-07 Application filed by Pfizer filed Critical Pfizer

2002-12-25 Application granted granted Critical

2002-12-25 Publication of DZ2227A1 publication Critical patent/DZ2227A1/fr

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

DZ970074A 1996-05-09 1997-05-07 Dérivés d'indole nouveaux, procédé pour leur préparation et formulations pharmaceutiques les contenant. DZ2227A1 (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9609641.7A GB9609641D0 (en)	1996-05-09	1996-05-09	Compounds useful in therapy

Publications (1)

Publication Number	Publication Date
DZ2227A1 true DZ2227A1 (fr)	2002-12-25

Family

ID=10793387

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DZ970074A DZ2227A1 (fr)	1996-05-09	1997-05-07	Dérivés d'indole nouveaux, procédé pour leur préparation et formulations pharmaceutiques les contenant.

Country Status (43)

Country	Link
US (4)	US6017945A (fr)
EP (1)	EP0901470B1 (fr)
JP (1)	JP3245179B2 (fr)
KR (1)	KR100331217B1 (fr)
CN (1)	CN1124262C (fr)
AP (1)	AP830A (fr)
AR (1)	AR007030A1 (fr)
AT (1)	ATE263151T1 (fr)
AU (1)	AU717849B2 (fr)
BG (1)	BG102873A (fr)
BR (1)	BR9709072A (fr)
CA (1)	CA2253876A1 (fr)
CO (1)	CO4650036A1 (fr)
CZ (1)	CZ292928B6 (fr)
DE (1)	DE69728392T2 (fr)
DK (1)	DK0901470T3 (fr)
DZ (1)	DZ2227A1 (fr)
EA (1)	EA001471B1 (fr)
ES (1)	ES2218675T3 (fr)
GB (1)	GB9609641D0 (fr)
HK (1)	HK1019149A1 (fr)
HN (1)	HN1997000058A (fr)
HR (1)	HRP970249B1 (fr)
HU (1)	HUP9901245A3 (fr)
ID (1)	ID16878A (fr)
IL (1)	IL125903A0 (fr)
IS (1)	IS1856B (fr)
MA (1)	MA26428A1 (fr)
NO (1)	NO312547B1 (fr)
NZ (1)	NZ332640A (fr)
OA (1)	OA10896A (fr)
PE (1)	PE65098A1 (fr)
PL (1)	PL329725A1 (fr)
PT (1)	PT901470E (fr)
SI (1)	SI0901470T1 (fr)
SK (1)	SK150398A3 (fr)
TN (1)	TNSN97078A1 (fr)
TR (1)	TR199802269T2 (fr)
TW (1)	TW491838B (fr)
UA (1)	UA50767C2 (fr)
UY (1)	UY24546A1 (fr)
WO (1)	WO1997043260A1 (fr)
ZA (1)	ZA973963B (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9722287D0 (en)	1997-10-22	1997-12-17	Pfizer Ltd	Compounds useful in therapy
PL205557B1 (pl) *	1999-02-10	2010-05-31	Astrazeneca Ab	Pochodne indolu
US20050203166A1 (en) *	2000-06-30	2005-09-15	Cancer Research Technology Limited	Indole-3-acetic acid derivatives
GB0016162D0 (en) *	2000-06-30	2000-08-23	Cancer Res Campaign Tech	Indole-3-acetic acid derivatives
TWI224101B (en)	2001-06-20	2004-11-21	Wyeth Corp	Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1)
DK1397130T3 (da)	2001-06-20	2007-11-12	Wyeth Corp	Substituerede indolsyrederivater som inhibitorer af plasminogenaktivatorinhibitor-1 (PAI-1)
AR037097A1 (es)	2001-10-05	2004-10-20	Novartis Ag	Compuestos acilsulfonamidas, composiciones farmaceuticas y el uso de dichos compuestos para la preparacion de un medicamento
DK1569900T3 (da)	2002-12-10	2006-10-23	Wyeth Corp	Substituerede 3-carbonyl-1-yl-eddikesyrederivater som inhibitorer af plasminogenaktivator-inhibitor-1 (PAI-1)
UA80453C2 (en)	2002-12-10	2007-09-25		Derivatives of substituted dyhydropyranoindol-3,4-dion as inhibitors of plasminogen activator inhibitor-1 (pai-1)
WO2004052854A2 (fr)	2002-12-10	2004-06-24	Wyeth	Derives d'acide 1h-indol-3-yl glyoxylique a substitution aryle, aryloxy et alkyloxy en tant qu'inhibiteurs de l'inhibiteur de l'activateur du plasminogene-1 (pai-1)
CA2509170A1 (fr)	2002-12-10	2004-06-24	Wyeth	Derives substitues de l'acide acetique de 3-alkyle et 3-arylalkyle 1h-indol-1-yle en tant qu'inhibiteurs de l'inhibiteur des activateurs du plasminogene (pai-1)
AU2003296323A1 (en)	2002-12-10	2004-06-30	Wyeth	Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
AU2004207740A1 (en) *	2003-01-22	2004-08-12	Eli Lilly And Company	Indole-derivative modulators of steroid hormone nuclear receptors
US7420083B2 (en)	2003-09-25	2008-09-02	Wyeth	Substituted aryloximes
US7446201B2 (en)	2003-09-25	2008-11-04	Wyeth	Substituted heteroaryl benzofuran acids
US7582773B2 (en)	2003-09-25	2009-09-01	Wyeth	Substituted phenyl indoles
US7342039B2 (en)	2003-09-25	2008-03-11	Wyeth	Substituted indole oximes
US7332521B2 (en)	2003-09-25	2008-02-19	Wyeth	Substituted indoles
US7141592B2 (en)	2003-09-25	2006-11-28	Wyeth	Substituted oxadiazolidinediones
US7265148B2 (en)	2003-09-25	2007-09-04	Wyeth	Substituted pyrrole-indoles
US7163954B2 (en)	2003-09-25	2007-01-16	Wyeth	Substituted naphthyl benzothiophene acids
US7411083B2 (en)	2003-09-25	2008-08-12	Wyeth	Substituted acetic acid derivatives
US7442805B2 (en)	2003-09-25	2008-10-28	Wyeth	Substituted sulfonamide-indoles
US7351726B2 (en)	2003-09-25	2008-04-01	Wyeth	Substituted oxadiazolidinediones
US7268159B2 (en)	2003-09-25	2007-09-11	Wyeth	Substituted indoles
JP2005109006A (ja) *	2003-09-29	2005-04-21	Tdk Corp	高電圧貫通型コンデンサ及びマグネトロン
HN2004000536A (es) *	2003-12-16	2009-02-18	Wyeth Corp	Un procediemiento de sintesis para la alquilacion reductiva de la posicon c-3 de indoles
AU2005277138A1 (en)	2004-08-23	2006-03-02	Wyeth Holdings Corporation	Oxazolo-naphthyl acids as plaminogen activator inhibtor type-1 (PAI-1) modulators useful in the treatment of thrombosis and cardiovascular diseases
BRPI0614340A2 (pt)	2005-08-17	2011-04-12	Wyeth Corp	indóis substituìdos e métodos de seu uso
AU2007237874A1 (en) *	2006-04-13	2007-10-25	Actelion Pharmaceuticals Ltd	Endothelin receptor antagonists for early stage idiopathic pulmonary fibrosis
DE102008030206A1 (de)	2008-06-25	2009-12-31	Bayer Schering Pharma Aktiengesellschaft	3-Cyanoalky- und 3-Hydroxyalkyl-Indole und ihre Verwendung
DE102008030207A1 (de)	2008-06-25	2009-12-31	Bayer Schering Pharma Aktiengesellschaft	Substituierte 7-Sulfanylmethyl-, 7-Sulfinylmethyl- und 7-Sulfonylmethyl-Indole und ihre Verwendung
CN106674065A (zh) *	2016-12-07	2017-05-17	贵州大学	一种5‑卤代‑2‑烷氧基‑4‑甲苯磺酰氯制备方法
GB201817038D0 (en) *	2018-10-19	2018-12-05	Inflazome Ltd	Novel processes
WO2020176599A1 (fr)	2019-02-27	2020-09-03	The Regents Of The University Of California	Azépino-indoles et autres hétérocycles pour traiter des troubles du cerveau

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE637352A (fr) *	1962-09-14
DE1950346B2 (de) *	1968-10-08	1973-06-28	Sumitomo Chemical Co	2-indolylessigsaeureverbindungen und diese verbindungen enthaltende arzneipraeparate
US4397079A (en) *	1981-03-30	1983-08-09	International Business Machines Corp.	Process for improving the yield of integrated devices including Schottky barrier diodes
US5245046A (en) *	1988-11-14	1993-09-14	The Upjohn Company	α-amino-indole-3-acetic acids useful as anti-diabetic, anti-obesity and anti-atherosclerotic agents
EP0548250B1 (fr) *	1990-09-10	1996-03-27	Rhone-Poulenc Rorer International (Holdings) Inc.	Composes aryles bicycliques substitues presentant une activite selective antagoniste contre les leucotrienes b4
ZA939516B (en) *	1992-12-22	1994-06-06	Smithkline Beecham Corp	Endothelin receptor antagonists
PT617001E (pt) *	1993-03-19	2000-06-30	Merck & Co Inc	Derivados do acido fenoxifenilacetico
GB9317096D0 (en) *	1993-08-17	1993-09-29	Pfizer Ltd	Indoles

1996
- 1996-05-09 GB GBGB9609641.7A patent/GB9609641D0/en active Pending
1997
- 1997-04-01 TW TW086104171A patent/TW491838B/zh not_active IP Right Cessation
- 1997-04-11 CN CN97194016A patent/CN1124262C/zh not_active Expired - Fee Related
- 1997-04-11 CZ CZ19983582A patent/CZ292928B6/cs not_active IP Right Cessation
- 1997-04-11 US US09/147,096 patent/US6017945A/en not_active Expired - Fee Related
- 1997-04-11 HU HU9901245A patent/HUP9901245A3/hu unknown
- 1997-04-11 CA CA002253876A patent/CA2253876A1/fr not_active Abandoned
- 1997-04-11 AU AU26978/97A patent/AU717849B2/en not_active Ceased
- 1997-04-11 SK SK1503-98A patent/SK150398A3/sk unknown
- 1997-04-11 IL IL12590397A patent/IL125903A0/xx unknown
- 1997-04-11 EP EP97920690A patent/EP0901470B1/fr not_active Expired - Lifetime
- 1997-04-11 TR TR1998/02269T patent/TR199802269T2/xx unknown
- 1997-04-11 PL PL97329725A patent/PL329725A1/xx unknown
- 1997-04-11 DE DE1997628392 patent/DE69728392T2/de not_active Expired - Fee Related
- 1997-04-11 DK DK97920690T patent/DK0901470T3/da active
- 1997-04-11 UA UA98115906A patent/UA50767C2/uk unknown
- 1997-04-11 ES ES97920690T patent/ES2218675T3/es not_active Expired - Lifetime
- 1997-04-11 EA EA199800908A patent/EA001471B1/ru not_active IP Right Cessation
- 1997-04-11 PT PT97920690T patent/PT901470E/pt unknown
- 1997-04-11 BR BR9709072A patent/BR9709072A/pt active Search and Examination
- 1997-04-11 WO PCT/EP1997/001882 patent/WO1997043260A1/fr active IP Right Grant
- 1997-04-11 JP JP54042397A patent/JP3245179B2/ja not_active Expired - Fee Related
- 1997-04-11 AT AT97920690T patent/ATE263151T1/de not_active IP Right Cessation
- 1997-04-11 KR KR1019980709023A patent/KR100331217B1/ko not_active IP Right Cessation
- 1997-04-11 SI SI9730646T patent/SI0901470T1/xx unknown
- 1997-04-11 NZ NZ332640A patent/NZ332640A/en unknown
- 1997-04-29 HN HN1997000058A patent/HN1997000058A/es unknown
- 1997-05-02 PE PE1997000345A patent/PE65098A1/es not_active Application Discontinuation
- 1997-05-07 TN TNTNSN97078A patent/TNSN97078A1/fr unknown
- 1997-05-07 ID IDP971517A patent/ID16878A/id unknown
- 1997-05-07 CO CO97024471A patent/CO4650036A1/es unknown
- 1997-05-07 AR ARP970101888A patent/AR007030A1/es not_active Application Discontinuation
- 1997-05-07 MA MA24599A patent/MA26428A1/fr unknown
- 1997-05-07 UY UY24546A patent/UY24546A1/es not_active IP Right Cessation
- 1997-05-07 DZ DZ970074A patent/DZ2227A1/fr active
- 1997-05-08 AP APAP/P/1997/000982A patent/AP830A/en active
- 1997-05-08 ZA ZA973963A patent/ZA973963B/xx unknown
- 1997-05-09 HR HR970249A patent/HRP970249B1/xx not_active IP Right Cessation
1998
- 1998-08-28 IS IS4838A patent/IS1856B/is unknown
- 1998-10-09 OA OA9800192A patent/OA10896A/en unknown
- 1998-10-27 BG BG102873A patent/BG102873A/xx unknown
- 1998-11-09 NO NO19985225A patent/NO312547B1/no not_active IP Right Cessation
1999
- 1999-10-06 HK HK99104349A patent/HK1019149A1/xx not_active IP Right Cessation
- 1999-10-07 US US09/414,361 patent/US6136843A/en not_active Expired - Fee Related
2000
- 2000-04-24 US US09/556,651 patent/US6306852B1/en not_active Expired - Fee Related
2001
- 2001-01-09 US US09/756,835 patent/US6384070B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
NO985225L (no)	1998-11-09
KR100331217B1 (ko)	2002-05-09
AR007030A1 (es)	1999-10-13
PE65098A1 (es)	1998-10-29
CZ358298A3 (cs)	1999-08-11
HN1997000058A (es)	1997-06-26
CA2253876A1 (fr)	1997-11-20
JP3245179B2 (ja)	2002-01-07
SI0901470T1 (en)	2004-08-31
AU2697897A (en)	1997-12-05
ES2218675T3 (es)	2004-11-16
AU717849B2 (en)	2000-04-06
IS4838A (is)	1998-08-28
BG102873A (en)	1999-11-30
JPH11508285A (ja)	1999-07-21
CO4650036A1 (es)	1998-09-03
EP0901470A1 (fr)	1999-03-17
CZ292928B6 (cs)	2004-01-14
HUP9901245A3 (en)	2002-01-28
DK0901470T3 (da)	2004-07-12
SK150398A3 (en)	1999-03-12
HUP9901245A2 (hu)	1999-08-30
US6306852B1 (en)	2001-10-23
UY24546A1 (es)	2000-09-29
PL329725A1 (en)	1999-04-12
AP830A (en)	2000-05-03
IS1856B (is)	2003-02-21
TR199802269T2 (xx)	2001-12-21
US6384070B2 (en)	2002-05-07
ID16878A (id)	1997-11-20
NZ332640A (en)	2001-03-30
BR9709072A (pt)	1999-08-03
AP9700982A0 (en)	1997-07-31
NO312547B1 (no)	2002-05-27
NO985225D0 (no)	1998-11-09
CN1216531A (zh)	1999-05-12
US6136843A (en)	2000-10-24
EA001471B1 (ru)	2001-04-23
ATE263151T1 (de)	2004-04-15
EP0901470B1 (fr)	2004-03-31
DE69728392D1 (de)	2004-05-06
GB9609641D0 (en)	1996-07-10
MA26428A1 (fr)	2004-12-20
ZA973963B (en)	1998-11-09
PT901470E (pt)	2004-07-30
TNSN97078A1 (fr)	2005-03-15
HRP970249A2 (en)	1998-06-30
DE69728392T2 (de)	2005-01-13
IL125903A0 (en)	1999-04-11
KR20000010879A (ko)	2000-02-25
US6017945A (en)	2000-01-25
CN1124262C (zh)	2003-10-15
HK1019149A1 (en)	2000-01-14
EA199800908A1 (ru)	1999-06-24
WO1997043260A1 (fr)	1997-11-20
OA10896A (en)	2001-10-11
HRP970249B1 (en)	2003-06-30
US20010014677A1 (en)	2001-08-16
TW491838B (en)	2002-06-21
UA50767C2 (uk)	2002-11-15

Publication	Publication Date	Title
DZ2227A1 (fr)	2002-12-25	Dérivés d'indole nouveaux, procédé pour leur préparation et formulations pharmaceutiques les contenant.
DZ2303A1 (fr)	2002-12-28	Dérivés d'indazole nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2300A1 (fr)	2002-12-25	Dérivés 6,5-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2299A1 (fr)	2002-12-25	Dérivés 6,6-hétérobicycliques substitués, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ1889A1 (fr)	2002-02-17	Dérivés de quinoléine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2197A1 (fr)	2002-12-02	Dérivés de 6-phénylpyridyl-2-amine, procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA26659A1 (fr)	2004-12-20	Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation.
DZ1957A1 (fr)	2002-02-17	Dérivés de pipéridine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2891A1 (fr)	2003-12-15	Dérivés de tétrahydroquinoléines substués nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2128A1 (fr)	2002-10-26	Composés nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ3042A1 (fr)	2004-03-27	Dérivés d'isothiazole nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2581A1 (fr)	2003-02-22	Dérivés d'acides aryloxyarylsulfonylaminohydroxamiques procédé pour leur préparation et compositionspharmaceutiques les contenant.
DZ2745A1 (fr)	2003-09-08	BicycloÄ2.2.1Üheptanes nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
MA26526A1 (fr)	2004-12-20	Derives d'indole inhibiteurs de cyclo-oxygenase, procede pour leur preparation et compositions pharmaceutiques les contenant.
DZ2523A1 (fr)	2003-02-01	Formulations pharmaceutiques contenant du voriconazole et procédé pour leur préparation.
DZ2634A1 (fr)	2003-03-08	Dérivés de pleuromutiline nouveaux procédé pour leur préparation et compositions pharmaceutiques lescontenant.
DZ2963A1 (fr)	2004-03-15	Dérivés de bicycliques substituées nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2890A1 (fr)	2003-12-15	4-Carboxamino-2-substitué-1,2,3,4-tétrahydroquinoléines, procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2758A1 (fr)	2003-09-15	Dérivés bicycliques d0acide hydroxamique nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2870A1 (fr)	2003-12-15	Dérivés d'acide hydroxypipécolate-hydroxamique nouveaux, procédé pour leur préparation et compositi ons pharmaceutiques les contenant.
FR2740136B1 (fr)	1998-01-09	Derives d'indolin-2-one, procede pour leur preparation et les compositions pharmaceutiques les contenant
DZ2777A1 (fr)	2003-12-01	Dérivés de quinazolinamines nouveaux procédé pour leur préparation et compositions pharmaceutiques les contenant.
DZ2962A1 (fr)	2004-03-15	Dérivés de 3-azabicycloÄ3,1,0Ühexane nouveaux, procédé pour leur préparation et compositions les contenant.
DZ2217A1 (fr)	2002-12-03	Dérivés d'imidazole substitués, procédé pour leur préparation et compositions les contenant.
MA26414A1 (fr)	2004-12-20	Derives de quinoleine et de quinazoline nouveaux, procede pour leur preparation et formulations pharmaceutiques les contenant.